Treatment Overview

The AML treatment that a patient receives depends on a number of factors, for example, age, other medical conditions and the specific type of AML that the person is suffering from.

Patients who are “fit” (no prior significant medical conditions) and under 70 years old are usually given intravenous (IV) chemotherapy, which requires hospitalisation for 3–4 weeks. Older and more “frail” (patients with serious prior medical conditions) patients may be given different treatment options, such as subcutaneous (applied under the skin) or oral (taken by the mouth) therapies.

Watch the videos in this section to learn more about various treatment options available for AML and to gain a better understanding of how to best approach your doctors with treatment questions.



Does the Clinical Trial Process Need an Extreme Makeover?

In this MythBusters program, patient advocate Jim Omel and Dr. Michael Thompson examine barriers patients may face and discuss the safety and quality of clinical trial care. Does the process need a makeover? Watch now to find out more.


Mind-Body Medicine: How Can Cancer Patients Utilize Supportive Care Therapy Tools?

Certified yoga therapist Raquel Jex Forsgren and expert oncologist Dr. Ishwaria Subbiah discuss the research-based benefits of mind-body practices for cancer patients. Join us to learn more on how to access supportive care tools before, during and after treatment.


What Are the Side Effect Profiles for Modern AML Treatments?

What potential side effects can AML patients expect from powerful new therapies? Expert, Dr. Ross Levine explains.


Chemo vs. Transplants: What Is the Purpose and Value of Each AML Treatment Method?

There are several treatment methods used for AML patients, but which one is right for you? AML expert Dr. Gwen Nichols gives information on procedure, purpose and value to help patients find the best approach.


An AML Treatment Revolution: Updates From an Expert

Dr. Naval Daver from The University of Texas MD Anderson Cancer Center joined Patient Power to discuss the dramatic progress being made in therapies for acute myeloid leukemia (AML).


When Should AML Patients Consider a Splenectomy?

AML expert Dr. Ross Levine explains why and when AML patients should consider getting a splenectomy. Tune in to learn more about AML treatment options.


AML Patient Insight: Resources to Consider to Help Reach Treatment Goals

How can AML patients establish a good foundation with their health care team and get the most out of doctor visits? Watch now to hear from our expert panel valuable tools for patients to use on their treatment journey.


Navigating AML Clinical Trials

AML expert Dr. Gwen Nichols discusses why clinical trials may be the best route for patients who are not responding to the standard of care. Watch now to find out more.


CAR T-Cell Therapy’s Role in AML Treatment

Can AML patients benefit from CAR T-cell therapy? Which patients are a good candidate for this type of treatment? Watch now to hear our ASH 2017 panel of AML experts discuss the latest research.


Showing 9 of 60 programs
Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 4, 2017